ArticleBiomedicines2025

Investigating the Impact of Ferric Derisomaltose (FDI) on Patient-Reported Quality-of-Life Outcome Measures in Iron-Deficient but Not Anaemic Patients with Chronic Kidney Disease.

Alisha Jafri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.